Previous close | 6.81 |
Open | 7.20 |
Bid | 7.10 |
Ask | 9.05 |
Strike | 127.00 |
Expiry date | 2024-05-31 |
Day's range | 7.20 - 7.20 |
Contract range | N/A |
Volume | |
Open interest | 118 |
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.